<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23697">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02798289</url>
  </required_header>
  <id_info>
    <org_study_id>OCUN-014</org_study_id>
    <nct_id>NCT02798289</nct_id>
  </id_info>
  <brief_title>Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator</brief_title>
  <official_title>A Single Arm, Multicenter, Open-Label Study Designed to Evaluate Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oculeve, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oculeve, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate acute tear production as measured by tear
      meniscus height (TMH) captured by optical coherence tomography (OCT) after single use of the
      Oculeve Intranasal Neurostimulator (OIN) in participants with dry eye.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, single-arm, multicenter, open-label clinical trial in which
      participants will use the OIN once following study enrollment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tear meniscus height captured by optical coherence tomography</measure>
    <time_frame>1-Day</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>Device Related Adverse Events</measure>
    <time_frame>22 days</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Dry Eye Syndrome</condition>
  <condition>Keratoconjunctivitis Sicca</condition>
  <arm_group>
    <arm_group_label>Active - Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Oculeve Intranasal Neurostimulator will be administered once to induce aqueous tear production once following study enrollment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oculeve Intranasal Neurostimulator</intervention_name>
    <description>Neurostimulation device</description>
    <arm_group_label>Active - Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with dry eye disease

          -  Literate, able to speak English or Spanish, and able to complete questionnaires
             independently

          -  Willing to sign the informed consent and deemed capable of complying with the
             requirements of the study protocol

        Exclusion Criteria:

          -  Chronic or recurrent epistaxis, coagulation disorders or other conditions that, in
             the opinion of the investigator, may lead to clinically significant increased
             bleeding

          -  Nasal or sinus surgery (including history of application of nasal cautery) or
             significant trauma

          -  Cardiac demand pacemaker, implanted defibrillator or other implanted electronic
             device

          -  Corneal transplant in either or both eyes

          -  Participation in any clinical trial with a new active substance or a new device
             within 30 days of the Screening Visit

          -  Women who are pregnant, planning a pregnancy, or nursing at the Screening Visit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil Friedman, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mid-Peninsula Ophthalmology Medical Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sall Research Medical Center</name>
      <address>
        <city>Artesia</city>
        <state>California</state>
        <zip>90701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aesthetic Eyecare Institute</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 26, 2017</lastchanged_date>
  <firstreceived_date>June 9, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Keratoconjunctivitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
